An in-vitro study of the sterol content and toxin production of Fusarium isolates from mycotic keratitis

References

1. Thomas PA, Geraldine P. Fungal keratitis due to Fusarium and other fungi. J Mycol Méd 1992; 2:121–131
   [Google Scholar]
2. Rajasekaran J, Thomas PA, Srinivasan R. Ketoconazole in keratomycosis. Blodi F, Brancato R, Cristini G. et al.Proceedings of the XXVth International Congress of Ophthalmology 19862462–2467
   [Google Scholar]
3. Chaiprasert A. Rare and unusual fungal diseases. Jacobs PH, Nall L. Antifungal drug therapy: a complete guide for the practitioner New York: Marcel Dekker Inc.; 1990279–296
   [Google Scholar]
4. Cuero RG. Ecological distribution of Fusarium solani and its opportunistic action related to mycotic keratitis in Cali, Colombia. J Clin Microbiol 1980; 12:455–461
   [Google Scholar]
5. Booth C. The genus Fusarium Buckinghamshire, England: Commonwealth Agricultural Bureau; 1985
   [Google Scholar]
6. Bhat RV, Ramakrishna Y, Beedu SR, Munshi KL. Outbreak of tricothecene mycotoxicosis associated with consumption of mould-damaged wheat products in Kashmir Valley, India. Lancet 1989; 1:35–37
   [Google Scholar]
7. Krogh P, Christensen DH, Hald B. et al. Natural occurrence of the mycotoxin fusarochromanone, a metabolite of Fusarium equiseti, in cereal feed associated with tibial dyschondroplasia. Appl Environ Microbiol 1989; 55:3184–3188
   [Google Scholar]
8. Yoshizawa T, Mirocha CJ, Behrens JC, Swanson SP. Metabolic fate of T-2 toxin in a lactating cow. Food Cosmet Toxicol 1981; 19:31–39
   [Google Scholar]
9. Weitzman I. Saprophytic molds as agents of cutaneous and subcutaneous infection in the immunocompromised host. Arch Dermatol 1986; 122:1161–1168
   [Google Scholar]
10. Wheeler MS, McGinnis MR, Schell WA, Walker DH. Fusarium infection in burned patients. Am J Clin Pathol 1981; 75:304–311
    [Google Scholar]
11. Anaissie E, Kantarjian H, Ro J. et al. The emerging role of Fusarium infections in patients with cancer. Medicine 1988; 67:77–83
    [Google Scholar]
12. Thomas PA, Abraham DJ, Kalavathy CM, Rajasekaran J. Oral itraconazole therapy for mycotic keratitis. Mycoses 1988; 31:271–279
    [Google Scholar]
13. Shadomy S, Espinel-Ingroff A, Cartwright RY. Laboratory studies with antifungal agents: susceptibility tests and bioassays. Lennette EH, Balows A, Hausler WJ, Shadomy HJ. Manual of clinical microbiology, 4th edn. Washington DC: American Society of Microbiology; 1985991–999
    [Google Scholar]
14. Howell SA, Moore MK, Mallet AI, Noble WC. Sterols of fungi responsible for superficial skin and nail infection. J Gen Microbiol 1990; 136:241–247
    [Google Scholar]
15. Raza SK, Howell SA, Mallet Aí. Identification of mycotoxins in keratomycosis-derived Fusarium isolates by gas chromatography-mass spectrometry. J Chromatogr Biomed Appl 1993; 620:243–249
    [Google Scholar]
16. Warnock DW. Methods with antifungal drugs. Evans EGV, Richardson MD. Medical mycology: a practical approach Oxford: IRL Oxford University Press; 1989235–259
    [Google Scholar]
17. vanden Bossche H, Marichal P, Odds FC, Le Jeune L, Coene MC. Characterisation of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 1992; 36:2602–2610
    [Google Scholar]
18. Howell SA, Mallet AI, Noble WC. A comparison of the sterol content of multiple isolates of the Candida albicans Darlington strain with other clinically azole-sensitive and -resistant strains. J Appl Bacteriol 1990; 69:692–696
    [Google Scholar]
19. Abbas HK, Mirocha CJ, Shier WT. Mycotoxins produced from fungi isolated from foodstuffs and soil: comparison of toxicity in fibroblasts and rat feeding tests. Appl Environ Microbiol 1984; 48:654–661
    [Google Scholar]
20. Bosch U, Mirocha CJ, Abbas HK, di Menna M. Toxicity and toxin production by Fusarium isolates from New Zealand. Mycopathologia 1989; 108:73–79
    [Google Scholar]
21. Mirocha CJ, Pathre SV, Schauerhamer B, Christensen CM. Natural occurrence of Fusarium toxins in feedstuff. Appl Environ Microbiol 1976; 32:553–556
    [Google Scholar]
22. Bhavanishankar TN, Ramesh HP, Shantha T. Dermal toxicity of Fusarium toxins in combinations. Arch Toxicol 1988; 61:241–244
    [Google Scholar]
23. Frisvad JC, Filtenborg O. Classification of Terverticilliate Penicillia based on profiles of mycotoxins and other secondary metabolites. Appl Environ Microbiol 1983; 46:1301–1310
    [Google Scholar]
24. Thrane U. Detection of toxigenic Fusarium isolates by thin layer chromatography. Lett Appl Microbiol 1986; 3:93–96
    [Google Scholar]
25. Drysdale RB, Bratt PM. Electrophoretic patterns of enzymes from isolates of Fusarium graminearum. Trans Br Mycol Soc 1971; 57:172–175
    [Google Scholar]